Impacts of Cytosolic Phospholipase A2, 15-Prostaglandin Dehydrogenase, and Cyclooxygenase-2 Expressions on Tumor Progression in Colorectal Cancer

키워드

참고문헌 (47)

1. Boyle P, "Descriptive epidemiology of colorectal cancer", Int J Cancer, 36, pp.9~18 (1985)
2. Ministry of Health and Welfare Republic of Korea, "Annual Report of the Korea Central Cancer Registry", ~ (2002)
3. Fearon ER, "A genetic model for colorectal tumorigenesis", Cell, 61, pp.759~767 (1990)
4. Williams CS, "The role of cyclooxygenases in inflammation, cancer, and development", Oncogene, 18, pp.7908~7916 (1999)
5. Fosslien E, "Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia", Crit Rev Clin Lab Sci, 37, pp.431~502 (2000)
6. Subbaramaiah K, "Cyclooxygenase 2: a molecular target for cancer prevention and treatment", Trends Pharmacol Sci, 24, pp.96~102 (2003)
7. Subbaramaiah K, "Inhibition of cyclooxygenase-2 gene expression by p53", J Biol Chem, 274, pp.10911~10915 (1999)
8. Yamauchi T, "Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer", Dis Colon Rectum, 45, pp.98~103 (2002)
9. Soumaoro LT, "Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer", Clin Cancer Res, 10, pp.8465~8471 (2004)
10. Fux R, "Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival", Clin Cancer Res, 11, pp.4754~4760 (2005)
11. Lim SC, "Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer", J Surg Oncol, 97, pp.51~56 (2008)
12. Needleman P, "Arachidonic acid metabolism", Ann Rev Biochem, 55, pp.69~102 (1986)
13. Balsinde J, "Regulation and inhibition of phospholipase A2", Annu Rev Pharmacol Toxicol, 39, pp.175~189 (1999)
14. Leslie CC, "Properties and regulation of cytosolic phospholipase A2", J Biol Chem, 272, pp.16709~16712 (1997)
15. Bonventre JV, "Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2", Nature, 390, pp.622~625 (1997)
16. Forsberg L, "Human glutathione dependent prostaglandin E synthase: gene structure and regulation", FEBS Lett, 471, pp.78~82 (2000)
17. Tanioka T, "Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis", J Biol Chem, 275, pp.32775~32782 (2000)
18. Murakami M, "Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2", J Biol Chem, 275, pp.32783~32792 (2000)
19. Trebino CE, "Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase", Proc Natl Acad Sci U S A, 100, pp.9044~9049 (2003)
20. Kamei D, "Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis", J Biol Chem, 278, pp.19396~19405 (2003)
21. Yoshimatsu K, "Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer", Clin Cancer Res, 7, pp.2669~2674 (2001)
22. van Rees BP, "Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines", Int J Cancer, 107, pp.551~556 (2003)
23. Ensor CM, "15-Hydroxyprostaglandin dehydrogenase", J Lipid Mediat Cell Signal, 12, pp.313~319 (1995)
24. Backlund MG, "15-Hydroxyprostaglandin dehydrogenase is downregulated in colorectal cancer", J Biol Chem, 280, pp.3217~3223 (2005)
25. Myung SJ, "15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis", Proc Natl Acad Sci U S A, 103, pp.12098~12102 (2006)
26. Thornton AD, "Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer", Br J Surg, 93, pp.1456~1463 (2006)
27. Panel V, "Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production", Cancer Lett, 243, pp.255~263 (2006)
28. Mehrotra S, "Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy", J Pathol, 208, pp.356~363 (2006)
29. Yoo NJ, "Expression of 15-hydroxyprostaglandin dehydrogenase, a COX-2 antagonist and tumour suppressor, is not altered in gastric carcinomas", Pathology, 39, pp.174~175 (2007)
30. Choi JY, "Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography", Ann Surg Oncol, 13, pp.1054~1062 (2006)
31. 임승철, "Expression of Cyclooxygenase-2 and its Relationship to p53 Accumulation in Colorectal Cancers", Yonsei Medical Journal, 48(3), pp.495~501 (2007), 연세대학교의과대학
32. Petersen S, "COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome", Anticancer Res, 22, pp.1225~1230 (2002)
33. Zhang H, "Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer", Am J Gastroenterol, 97, pp.1037~1041 (2002)
34. Takaku K, "Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene", J Biol Chem, 275, pp.34013~34016 (2000)
35. Hong KH, "Deletion of cytosolic phosholipase A(2) suppresses Apc(Min)-induced tumorigenesis", Proc Natl Acad Sci U S A, 98, pp.3935~3939 (2001)
36. Dong M, "Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis", Carcinogenesis, 24, pp.307~315 (2003)
37. Ilsley JN, "Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis", Cancer Res, 65, pp.2636~2643 (2005)
38. Soydan AS, "High molecular weight phospholipase A2 and fatty acids in human colon tumors and associated normal tissue", Eur J Cancer, 32A, pp.1781~1787 (1996)
39. Dimberg J, "Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer", Anticancer Res, 18, pp.3283~3287 (1998)
40. Wendum D, "COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinoma compared with colorectal adenocarcinomas", Mod Pathol, 16, pp.130~136 (2003)
41. Dong M, "Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis", Clin Cancer Res, 11, pp.2265~2271 (2005)
42. Laye JP, "Phospholipase A2 expression in tumors: a target for therapeutic intervention?", Drug Discov Today, 8, pp.710~716 (2003)
43. Yoshimatsu K, "Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenoma and cancer", Clin Cancer Res, 7, pp.3971~3976 (2001)
44. Nakanishi M, "Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis", Cancer Res, 68, pp.3251~3259 (2008)
45. Yan M, "15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers", Proc Natl Acad Sci U S A, 101, pp.17468~17473 (2004)
46. Wolf I, "15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer", Cancer Res, 66, pp.7818~7823 (2006)
47. Gee JR, "Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder", Urol Oncol, 21, pp.266~270 (2003)

관련 논문AI추천